Taken together, these findings provide further evidence that Setd1a haploinsufficiency, early in development, may have a more generic effect on biological mechanisms, rather than specifically targeting pathways known to be implicated in schizophrenia. The gene discussed is SETD1A; the disease is schizophrenia.